Showing results (41-50 of 95) with videos related to

Sort By:
Pageof 10
Biochemistry|June 2, 2020
Enzyme-Substrate-Cofactor Dynamical Networks Revealed by High-Resolution Field Cycling RelaxometryMasha M Rosenberg, Tianjiong Yao, Gregory C Patton, et al.
The Journal of Biological Chemistry|January 25, 2005
The functional basis of mycophenolic acid resistance in Candida albicans IMP dehydrogenaseGerwald A Köhler, Xin Gong, Stefan Bentink, et al.
Bioorganic & Medicinal Chemistry Letters|December 26, 2022
Nonhydrolyzable d‑phenylalanine-benzoxazole derivatives retain antitubercular activityMichael J Pepi, Shibin Chacko, Nicole Kopetz, et al.
Biochimie|May 7, 2018
Sabellastarte magnifica Carboxypeptidase Inhibitor: The first Kunitz inhibitor simultaneously interacting with carboxypeptidases and serine proteasesMey Ling Reytor González, Maday Alonso-Del-Rivero Antigua, Lizbeth Hedstrom, et al.
Chemistry & Biology|November 2, 2010
Structural determinants of inhibitor selectivity in prokaryotic IMP dehydrogenasesDeviprasad R Gollapalli, Iain S Macpherson, George Liechti, et al.
The Journal of Biological Chemistry|June 22, 2002
Comparative trajectories of active and S195A inactive trypsin upon binding to serpinsPhilippe Mellet, Yves Mély, Lizbeth Hedstrom, et al.
Mbio|February 23, 2017
<i>Mycobacterium tuberculosis</i> Proteasome Accessory Factor A (PafA) Can Transfer Prokaryotic Ubiquitin-Like Protein (Pup) between SubstratesSusan Zhang, Kristin E Burns-Huang, Guido V Janssen, et al.
Acta Crystallographica. Section F, Structural Biology Communications|May 7, 2015
Structure of Cryptosporidium IMP dehydrogenase bound to an inhibitor with in vivo antiparasitic activityYoungchang Kim, Magdalena Makowska-Grzyska, Suresh Kumar Gorla, et al.
Advances in Experimental Medicine and Biology|March 19, 2010
Investigating the mechanism of disease in the RP10 form of retinitis pigmentosaCatherine J Spellicy, Dong Xu, Garrett Cobb, et al.
The Journal of Biological Chemistry|August 27, 2014
Prion-like nanofibrils of small molecules (PriSM) selectively inhibit cancer cells by impeding cytoskeleton dynamicsYi Kuang, Marcus J C Long, Jie Zhou, et al.
Pageof 10